Chakra Aromatherapy for Nurses (Aromatherapy)

February 24, 2026 updated by: chung hui ting, Fu Jen Catholic University Hospital

A Randomized Controlled Trial of Chakra-Based Aromatherapy Intervention for Stress Reduction, Mental Well-being, and Sleep Quality in Healthcare Workers

This randomized controlled trial investigates the effects of chakra-based aromatherapy on stress, mental state, and sleep quality among nurses. Participants in the intervention group will receive chakra-based essential oil inhalation and massage, while the control group will receive routine care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Intervention measures in the experimental group:Chakra-based Aromatherapy: Participants will receive chakra-based aromatherapy using essential oils applied with inhalation and massage, 30 minutes per session, 5 times per week, for 4 weeks.The control group wasRoutine Care: Participants will continue with routine care and will not receive aromatherapy intervention.

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taiwan (r.o.c.)
      • New Taipei City, Taiwan (r.o.c.), Taiwan, 24352
        • Fu Jen Catholic University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Registered nurses working in hospital settings
  • Willing to participate and provide written informed consent

Exclusion Criteria:

  • Atopic dermatitis
  • Respiratory disease
  • Pregnancy or lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
Chakra-based Aromatherapy: Participants will receive chakra-based aromatherapy using essential oils applied with inhalation and massage, 30 minutes per session, 5 times per week, for 4 weeks.
Chakra-based Aromatherapy: Participants will receive chakra-based aromatherapy using essential oils applied with inhalation and massage, 30 minutes per session, 5 times per week, for 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1.Chinese version of the Pittsburgh Sleep Quality Scale 2.Stress index measuring table
Time Frame: 4 weeks
  1. The Chinese version of the Pittsburgh Sleep Quality Scale is a self-report questionnaire with nine questions. It primarily assesses sleep quality and sleep volume over the past month. The questionnaire content is copyrighted by Professor Liu Pei-Shan of the Graduate Institute of Nursing, Taipei Medical University. The questionnaire cons
  2. This stress scale contains 12 questions. Please answer "yes" or "no" based on your current situation. Stress index answers: 3 "yes": Your stress level is still within a manageable range. 4-5 "yes": Stress is quite bothering you. Although you can manage it, you need to seriously learn stress management and talk to good mentors and friends. 6-8 "yes": Your stress is very high. See a mental health professional as soon as possible for systematic psychotherapy. 9 or more "yes": Your stress is very serious. You should see a psychiatrist and follow their prescription for medication and psychotherapy to help your life return to normal as soon as possible.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Symptom Rating Scale
Time Frame: 4 weeks

This scale includes a set of five symptom items. The "suicidal ideation" item is assessed separately, with a score of 6 or higher being the cutoff for screening.

The Short Form Health Scale (BSRS-5) asks patients to recall the degree of distress or anxiety they have felt over the past week (including the day of assessment). A total BSRS-5 score of ≤3 may rule out suicidal risk. It is recommended to first inquire about the presence of symptoms, and then determine the severity if present. The BSRS-5 score ranges from 0 to 20, and is categorized into several levels based on the score:

<6 points: Normal range, indicating a good mood. 6-9 points: Mild, stress management is recommended; talk to family or friends to express emotions.

10-14 points: Moderate, professional counseling is recommended; seek psychological counseling or receive professional help.

15 points or above: Severe, requires high level of care; seek professional guidance or psychiatric treatment.

4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., Kunaviktikul, W., Klunklin, A., Chanthapoon, C., & Chaiyasut, C. (2022). Essential oils, phytoncides, aromachology, and aromatherapy-A review. Applied Sciences, 12(9), 4495. https://doi.org/10.3390/app12094495

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 22, 2024

Primary Completion (Actual)

October 31, 2024

Study Completion (Actual)

October 31, 2025

Study Registration Dates

First Submitted

February 13, 2026

First Submitted That Met QC Criteria

February 24, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FJUH113388
  • PL-202408015-M (Other Grant/Funding Number: CHUNG HUI TING)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected IPDs, and all IPDs that contribute to the publication results

IPD Sharing Time Frame

Starts 1 year after publication, no end date

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supportive Therapy

Clinical Trials on Aromatherapy

Subscribe